Hyperkalemia: Clinical Trials

1 trial for Hyperkalemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Enrolling by invitation 1

Follow Hyperkalemia: new trials by email Literature Review of Hyperkalemia trials Research Report on Hyperkalemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes
Phase 4Enrolling by invitationBaylor Research Institute642026-04-082026-10-13

Narrower conditions

Albuminuria (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Chronic Disease (1)  ·  Diabetes Mellitus (1)  ·  Disease Attributes (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glucose Metabolism Disorders (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Proteinuria (1)  ·  Renal Insufficiency (1)

Interventions

(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1)  ·  Canagliflozin (1)  ·  Captopril (1)  ·  Enalapril (1)  ·  Fosinopril (1)  ·  Irbesartan (1)  ·  Lisinopril (1)  ·  Losartan (1)  ·  Olmesartan Medoxomil (1)  ·  Perindopril (1)  ·  Quinapril (1)  ·  Ramipril (1)  ·  Telmisartan (1)  ·  Valsartan (1)  ·  azilsartan (1)

Sponsors

Baylor Research Institute (1)

Countries

United States (1)